Home

Gilde Healthcare Holding B.V.

CIK 1420106 · last filed 2026-08-28

Gilde Healthcare Holding B.V. is a corporate insider who has filed 17 SEC Form 4 insider transactions across 5 companies since 2018. The most recent filing shows the insider sold $27.0K of SI on Aug 28, 2026. Across all open-market trades the lifetime net is −$611.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $44.4M across reported positions. The firm reports its address in 3508 Utrecht. 16 SEC filings were submitted jointly with Gilde Healthcare IV U.A. Cooperatieve.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$44.42M

Companies

5

Total Filings

17

Lifetime Open-Market Net

-$611.49M

Filer Profile

Reported Address
NEWTONLAAN 91
PO BOX 85067
3508 UTRECHT
Phone
31(0)30-2192549
State of Incorporation
Netherlands
Related Filers
Gilde Healthcare IV U.A. Cooperatieve — 16 joint filings, latest 2025-10-20
Gilde Healthcare IV Management B.V. — 14 joint filings, latest 2025-04-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SI 10%+ Owner 2,185,914 $20.32 $44.42M -$3.15M 7 2026-08-28
LAVA Therapeutics NV (LVTX) Delisted 10%+ Owner 5,294,178 $1.74 $9.21M -$395.8K 1 2025-10-10
Eargo, Inc. (EAR) Delisted 10%+ Owner 181,876 $2.57 $467.4K -$28.44M 5 2021-04-27
Inari Medical, Inc. (NARI) Delisted 10%+ Owner 5,746,828 $79.97 $459.57M -$580.80M 2 2021-03-16
VAPOTHERM INC (VAPO) Delisted 10%+ Owner 148,628 $2.17 $322.5K $1.29M 1 2018-11-20

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-28 SI Sell (S) −1,196 -$27.0K EDGAR
2026-08-24 SI Sell (S) −25,097 -$567.4K EDGAR
2026-08-07 SI Sell (S) −9,433 -$213.5K EDGAR
2026-08-07 SI Sell (S) −9,433 -$213.5K EDGAR
2026-08-05 SI Sell (S) −110,563 -$2.52M EDGAR
2026-08-03 SI Sell (S) −48,279 -$1.12M EDGAR
2026-07-29 SI Notice (144) −200,000 -$4.85M EDGAR
2025-10-10 LAVA Therapeutics NV (LVTX) Delisted Sell (S) −253,984 -$395.8K EDGAR
2025-08-05 SI Mixed +2,380,482 $1.50M EDGAR
2021-04-27 Eargo, Inc. (EAR) Delisted Sell (S) −512,367 -$26.94M EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.